0001672726-16-000001.txt : 20160421 0001672726-16-000001.hdr.sgml : 20160421 20160420182459 ACCESSION NUMBER: 0001672726-16-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160421 DATE AS OF CHANGE: 20160420 EFFECTIVENESS DATE: 20160421 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Medicenna Therapeutics Inc. CENTRAL INDEX KEY: 0001672726 IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-261759 FILM NUMBER: 161582219 BUSINESS ADDRESS: STREET 1: 439 HELMCKEN STREET CITY: VANCOUVER STATE: A1 ZIP: V6B 2E6 BUSINESS PHONE: 604-671-6673 MAIL ADDRESS: STREET 1: 439 HELMCKEN STREET CITY: VANCOUVER STATE: A1 ZIP: V6B 2E6 D 1 primary_doc.xml X0707 D LIVE 0001672726 Medicenna Therapeutics Inc. 439 HELMCKEN STREET VANCOUVER A1 BRITISH COLUMBIA, CANADA V6B 2E6 604-671-6673 BRITISH COLUMBIA, CANADA None None Corporation true 2011 FAHAR MERCHANT 439 HELMCKEN STREET VANCOUVER A1 BRITISH COLUMBIA, CANADA V6B 2E6 Executive Officer Director Biotechnology Decline to Disclose 06b false 2016-04-05 false true true true Warrants exercisable into equity. false 0 798336 798336 0 399,168 special warrants were sold at a price per special warrant of $2.00. Warrants to purchase an additional 18,000 shares of common stock were issued in connection with pre-existing contractual rights for no additional consideration. false 1 0 0 150000 true Repayment of loan from executive officer of the registrant made in connection with the registrant?s research and development program. false Medicenna Therapeutics Inc. /s/ Fahar Merchant Fahar Merchant President and Chief Executive Officer 2016-04-20